MEI Pharma Inc. has announced a private placement agreement to raise approximately $100 million through the sale of 29,239,767 shares of common stock at $3.42 per share. The proceeds will be dedicated to implementing a Litecoin Treasury Strategy, marking MEI Pharma as the first publicly traded company on a national exchange to hold Litecoin. Charlie Lee, the founder of Litecoin and a lead investor in the transaction, will join MEI's Board of Directors upon closing, replacing current member Taheer Datoo. GSR will oversee the company's digital asset and treasury management. Titan Partners Group is acting as the sole placement agent for this transaction, which is expected to close around July 22, 2025, pending customary closing conditions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MEI Pharma Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250718252887) on July 18, 2025, and is solely responsible for the information contained therein.
Comments